InspireMD Inc Share Price Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
Sales 2024 * | 7.09M 558M | Sales 2025 * | 14.65M 1.15B | Capitalization | 56.9M 4.48B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 8.02 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.64% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 31/12/19 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 30/03/11 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 12/10/20 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 31/12/19 |
Thomas Kester
BRD | Director/Board Member | 77 | 05/09/16 |
1st Jan change | Capi. | |
---|---|---|
-5.21% | 182B | |
+1.63% | 114B | |
-5.34% | 67.76B | |
+4.25% | 51.91B | |
+7.28% | 43.23B | |
+6.07% | 41.07B | |
+22.76% | 32.07B | |
+15.86% | 25B | |
-2.48% | 24.55B |